15 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 7 | 0 | 0 | 3 |
| Last 30D | 0 | 0 | 0 | 0 | 1 |
| 1M Ago | 1 | 1 | 0 | 0 | 2 |
| 2M Ago | 3 | 4 | 0 | 0 | 0 |
| 3M Ago | 1 | 2 | 0 | 0 | 0 |
Analysts have recently evaluated Sarepta Therapeutics and provided 12-month price targets. The average target is $158.87, accompanied by a high estimate of $205.00 and a low estimate of $75.00. This current average has decreased by 5.25% from the previous average price target of $167.67.
Deciphering Analyst Ratings: An In-Depth Analysis
The perception...
Login or create a forever free account to read this news
Sign up/Log in
